A Powerful Natural Antioxidant for Health and Beauty

Alpha Lipoic Acid References - Section IV

  1. Singh, Akanksha, et al., et al. Natural Antioxidants and Their Role in Cancer Prevention. [ed.] Sharmila Shankar and Rakesh K. Srivastava. Nutrition, Diet and Cancer. New York: Springer Science+Business Media B.V., 2012, 23, pp. 563-584. ISBN 978-94-007-2922-3; DOI: 10.1007/978-94-007-2923-0.
  2. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Shay, Kate Petersen, et al., et al. [ed.] E. Arnér and S.S. Krag. 10, Stockholm; Baltimore: Elsevier B.V., October 2009, Biochimica et Biophysica Acta (BBA) - General Subjects, Vol. 1790, pp. 1149-1160. DOI: 10.1016/j.bbagen.2009.07.026; http://www.sciencedirect.com/science/article/pii/S0304416509002153. ISSN: 0304-4165.
  3. Anti-obesity effects of a-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Kim, Min-Seon, et al., et al. [ed.] Juan Carlos López. 7, New York: Nature Publishing Group, July 2004, Nature Medicine, Vol. 10, pp. 727-733. DOI: 10.1038/nm1061; http://www.nature.com/nm/journal/v10/n7/full/nm1061.html. ISSN: 1078-8956.
  4. Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases. Berkson, Burton M., Rubin, Daniel M. and Berkson, Arthur J. [ed.] Keith I. Block. 4, Chicago: Sage Publications, December 2009, Integrative Cancer Therapies, Vol. 8, pp. 416-422. ISSN: 1534-7354.
  5. Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Guais, Adeline, et al., et al. [ed.] Eric K. Rowinsky. 1, s.l.: Springer Science+Business Media, LLC, February 2012, Investigational New Drugs, Vol. 30, pp. 200-211. DOI: 10.1007/s10637-010-9552-x; http://link.springer.com/article/10.1007%2Fs10637-010-9552-x. ISSN: 0167-6997.
  6. A Phase II Study with Antioxidants, Both in the Diet and Supplemented, Pharmaconutritional Support, Progestagen, and Anti-Cyclooxygenase-2 Showing Efficacy and Safety in Patients with Cancer-Related Anorexia/Cachexia and Oxidative Stress. Mantovani, Giovanni, et al., et al. [ed.] Timothy R. Rebbeck. 5, Philadelphia: American Association for Cancer Research, May 2006, Cancer Epidemiology, Biomarkers & Prevention, Vol. 15, pp. 1030-1034. DOI: 10.1158/1055-9965.EPI-05-0538; http://cebp.aacrjournals.org/content/15/5/1030. ISSN: 1055-9965.
  7. Effective Treatment of Oxaliplatin-Induced Cumulative Polyneuropathy With Alpha-Lipoic Acid. Gedlicka, C., et al., et al. [ed.] Daniel G. Haller. 15, Alexandria. Gedlicka, C., et al., et al. [ed.] Daniel G. Haller. 15, Alexandria: American Society of Clinical Oncology, August 1, 2002, Journal of Clinical Oncology, Vol. 20, pp. 3359-3361. DOI: 10.1200/JCO.2002.99.502; http://jco.ascopubs.org/content/20/15/3359. ISSN: 0732-183X.
  8. Weber, Stefan U., et al., et al. Antioxidants. [ed.] André O. Barel, Marc Paye and Howard I. Maibach. Handbook of Cosmetic Science and Technology. 3rd. New York: Informa Healthcare USA, Inc., 2009, 28, pp. 301-310. ISBN-13: 978-1-4200-6963-1.
  9. Strayer, David S. and Rubin, Emanuel. Cell Adaptation, Cell Injury and Cell Death. [ed.] Raphael Rubin, David S. Strayer and Emanuel Rubin. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 6. Philadelphia: Wolters Kluwer: Lippincott Williams & Wilkins, 2012, 1, pp. 1-46. ISBN: 978-1-60547-968-2.
  10. Perricone, Nicholas V. Cellular Rejuvenation. 7 Secrets to Beauty, Health, and Longevity. Crows Nest: Griffin Press: Allen & Unwin, 2006, 1, pp. 3-36. ISBN: 978-1-74175-209-0.
  11. Small molecule modulators of antioxidant response pathway. Hur, Wooyoung and Gray, Nathanael S. [ed.] Benjamin G. Davis. 1, Oxford: Elsevier Ltd., February 2011, Current Opinion in Chemical Biology, Vol. 15, pp. 162-173. DOI: 10.1016/j.cbpa.2010.12.009; http://www.sciencedirect.com/science/article/pii/S1367593110001985. ISSN: 1367-5931.
  12. Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Afaq, Farrukh, Adhami, Vaqar M. and Mukhtar, Hasan. [ed.] P.J. Stambrook, L.H.F. Mullenders and L.R. Ferguson. 1-2, Cincinnati; Leiden; Auckland: Elsevier B.V., April 1, 2005, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 571, pp. 153-173. DOI: 10.1016/j.mrfmmm.2004.07.019; http://www.sciencedirect.com/science/article/pii/S0027510704004920. ISSN: 0027-5107.
  13. Boik, John. Natural Compounds in Cancer Therapy: Promising Nontoxic Antitumor Agents from Plants & Other Natural Sources. [ed.] Silvine Farnell. s.l.: Oregon Medical Press, LLC, 2001. ISBN: 0-9648280-1-4.
  14. Shishodia, Shishir, Singh, Tulika and Chaturvedi, Madan M. Modulation of Transcription Factors by Curcumin. [ed.] Bharat B. Aggarwal, Young-Joon Surh and Shishir Shishodia. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. New York: Springer Science+Business Media, LLC, 2007, pp. 127-148. ISBN-13: 978-0-387-46400-8.
  15. Screening of well-established drugs targeting cancer metabolism: reproducibility of the efficacy of a highly effective drug combination in mice. Abolhassani, Mohammad, et al., et al. [ed.] Daniel G. Haller. 15, Alexandria. Hur, Wooyoung and Gray, Nathanael S. [ed.] Eric K. Rowinsky. 2, New York: Springer Science+Business Media, LLC, April 2013, Investigational New Drugs, Vol. 31, pp. 256-64. DOI: 10.1007/s10637-011-9692-7; http://link.springer.com/article/10.1007%2Fs10637-011-9692-7. ISSN: 0167-6997.
  16. Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin. Schwartz, Laurent, et al., et al. [ed.] Eric K. Rowinsky. 4, s.l.: Springer Science+Business Media, LLC, August 2012, Investigational New Drugs: The Journal of New Anticancer Agents, Vol. 30, pp. 1331-1342. DOI: 10.1007/s10637-012-9849-z; http://link.springer.com/article/10.1007%2Fs10637-012-9849-z. ISSN: 0167-6997.
  17. α-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells. Lee, Hyun Sook, Na, Mi Hee, Kim, Woo Kyoung. [ed.] Bruce A. Watkins. 6, s.l.: Elsevier Inc., June 2010, Nutrition Research, Vol. 30, pp. 403-409. DOI: 10.1016/j.nutres.2010.06.009; http://www.nrjournal.com/article/S0271-5317(10)00114-4/abstract. ISSN: 0271-5317.
  18. Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo. Feuerecker, Benedikt, et al., et al. [ed.] Wafik S. El-Deiry. 14, s.l.: Landes Bioscience, December 2012, Cancer Biology & Therapy, Vol. 13, pp. 1425-1435. DOI: 10.4161/cbt.22003; http://www.tandfonline.com/doi/abs/10.4161/cbt.22003. ISSN: 1538-4047.
  19. Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. Rossi, Cosmo, et al., et al. [ed.] Alexander M.M. Eggermont. 17, Oxford: Elsevier Ltd., November 2008, European Journal of Cancer, Vol. 44, pp. 2696-2704. DOI: 10.1016/j.ejca.2008.08.021; http://www.ejcancer.com/article/S0959-8049(08)00683-7/abstract. ISSN: 0959-8049.
  20. Lipoic Acid: A New Antiangiogenic Molecule? Benelli, R., et al., et al. [ed.] Franco Zunino. Genoa: Il Pensiero Scientifico Editore: Fondazione IRCCS - Istituto Nazionale dei Tumori , 2004, TUMORI - Tumor Invasion and Metastasis, p. 162. ISSN: 0300-8916.
  21. Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells. Simbula, G., et al., et al. [ed.] Mels Sluyser. 1, Amsterdam: Kluwer Academic Publishers, January 2007, Apoptosis, Vol. 12, pp. 113-123. DOI: 10.1007/s10495-006-0487-9; http://link.springer.com/article/10.1007%2Fs10495-006-0487-9. ISSN: 1360-8185.
  22. Chemopreventive effects of natural dietary compounds on cancer development. Pan, Min-Hsiung and Ho, Chi-Tang. [ed.] Robert D. Eagling. 11, Cambridge, UK: The Royal Society of Chemistry, 2008, Chemical Society Reviews, Vol. 37, pp. 2558-2574. DOI: 10.1039/b801558a; http://pubs.rsc.org/en/Content/ArticleLanding/2008/CS/b801558a#!divAbstract. ISSN: 0306-0012.
  23. The Long-term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol. Berkson, Burton M., Rubin, Daniel M. and Berkson, Arthur J. [ed.] Keith I. Block. 1, Evanston: SAGE Publications, March 2006, Integrative Cancer Therapies, Vol. 5, pp. 83-89. DOI: 10.1177/1534735405285901; http://ict.sagepub.com/content/5/1/83. ISSN: 1534-7354.
  24. Mechanism of suppressive effect of lipoic acid on the UVB-induced erythema reaction in vivo. Bito, T., et al., et al. Montréal, Quebec: Journal of Investigative Dermatology, 2009. Society for Investigative Dermatology 2009 Annual Meeting. Vol. 129, p. S45. 269.
  25. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line. Choi, Hyun-Jeung, et al., et al. [ed.] William C. Eckelman. 8, s.l.: Elsevier Inc., November 2012, Nuclear Medicine and Biology, Vol. 39, pp. 1275-1280. DOI: 10.1016/j.nucmedbio.2012.08.007; http://www.nucmedbio.com/article/S0969-8051(12)00224-7/abstract. ISSN: 0969-8051.
  26. Hechtman, Leah, Harris, Kathy and Bridgeman, Karen. The Immune System. [ed.] Leah Hechtman. Clinical Naturopathic Medicine. Revised. Chatswood: Elsevier Australia, 2012, 9, pp. 280-417. ISBN: 978-0-7295-3885-5.
  27. Amelioration of docetaxel/cisplatin induced polyneuropathy by α-lipoic acid. Gedlicka, C., et al., et al. [ed.] David Kerr. 2, Oxford: Oxford University Press: European Society Medical Oncology, February 2003, Annals of Oncology, Vol. 14, pp. 339-340. DOI: 10.1093/annonc/mdg051; http://annonc.oxfordjournals.org/content/14/2/339. ISSN: 0923-7534.
  28. The possible protective effect of antioxidant Alpha-lipoic acid on the liver of pregnant albino rat and its offspring treated with Doxorubicin. Mahasen, Laila M.Aboul, Donya, Souria M. and Mohamed, Amany F. [ed.] Hongbao Ma. 2, New York: Marsland Press, February 25, 2012, Researcher: Report and Opinion, Vol. 4, pp. 25-35. ISSN: 1553-9865.
  29. Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells. Prahalathan, C., et al., et al. [ed.] H.W.J. Marquardt and K.B. Wallace. 3, Shannon: Elsevier Ireland Ltd., May 15, 2006, Toxicology, Vol. 222, pp. 225-232. DOI: 10.1016/j.tox.2006.02.015; http://www.sciencedirect.com/science/article/pii/S0300483X06001326. ISSN: 0300-483X.
  30. Alpha-Lipoic Acid Ameliorates Myocardial Toxicity Induced by Doxorubicin. Al-Majed, Abdulhakeem A., et al., et al. [ed.] Francesco Visioli. 6, s.l.: Elsevier Ltd., December 2002, Pharmacological Research, Vol. 46, pp. 499-503. DOI: 10.1016/S1043661802002311; http://www.sciencedirect.com/science/article/pii/S1043661802002311. ISSN: 1043-6618.
  31. Male Fertility-Implications of Anticancer Treatment and Strategies to Mitigate Gonadotoxicity. Ragheb, Ahmed M. and Jr., Edmund S. Sabanegh. [ed.] Michelle Prudhomme. 1, Aubiere Cedex: Bentham Science Publishers Ltd., January 2010, Anti-Cancer Agents in Medicinal Chemistry, Vol. 10, pp. 92-102. DOI: 10.2174/1871520611009010092; http://www.eurekaselect.com/70830/article. ISSN: 1871-5206.
  32. Therapeutic effects of alpha-lipoic acid on bleomycin-induced pulmonary fibrosis in rats. Liu, Rui, et al., et al. [ed.] Demetrios A. Spandidos. 6, Athens: Spandidos Publications Ltd., June 2007, International Journal of Molecular Medicine, Vol. 19, pp. 865-873. DOI: 10.3892/ijmm.19.6.865; http://www.spandidos-publications.com/10.3892/ijmm.19.6.865. ISSN: 1107-3756.
  33. Marcovitch, Harvey. Black's Medical Dictionary. 41. London: A & C Black Publishers Limited, 2005. ISBN: 0-7136-6146-1.
  34. Alfa-Lipoic Acid Controls Tumor Growth and Modulates Hepatic Redox State in Ehrlich-Ascites-Carcinoma-Bearing Mice. Abdan, M. AL. [ed.] Chrisostomos Prodromou. Article ID 509838, Sussex: Hindawi Publishing Corporation, May 1, 2012, The Scientific World Journal, Vol. 2012, pp. 1-6. DOI: 10.1100/2012/509838; http://www.hindawi.com/journals/tswj/2012/509838/. ISSN: 1537-744X.
  35. Allen, Jeffrey. Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy. U.S. National Institutes of Health: Clinical Trials.gov. [Online] September 26, 2014. [Cited: November 24, 2015.] http://clinicaltrials.gov/show/NCT01313117. ClinicalTrials.gov Identifier: NCT01313117.
  36. α-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model. Perra, Andrea, et al., et al. [ed.] Curtis C. Harris. 1, Bethesda: Oxford University Press, January 2008, Carcinogenesis, Vol. 29, pp. 161-168. DOI: 10.1093/carcin/bgm205; http://carcin.oxfordjournals.org/content/29/1/161. ISSN: 0143-3334.
  37. Pressman, Alan H. and Buff, Sheila. The Complete Idiot's Guide to Vitamins and Minerals. New York: Alpha Books: Simon and Schuster Macmillan Company, 1997. ISBN: 0-02-862116-6.
  38. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice. Min, Ae-Kyung, et al., et al. [ed.] Frank Porreca. 5-6, Tucson: Elsevier B.V., January 30, 2012, Life Sciences, Vol. 90, pp. 200-205. DOI: 10.1016/j.lfs.2011.11.012; http://www.sciencedirect.com/science/article/pii/S0024320511005741. ISSN: 1674-7305.
  39. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi, Yoshihisa, Soejima, Yurie and Fukusato, Toshio. [ed.] Ferruccio Bonino, et al., et al. 19, Hong Kong: Baishideng Publishing Group Co., Limited, May 21, 2012, World Journal of Gastroenterology, Vol. 18, pp. 2300-2308. DOI: 10.3748/wjg.v18.i19.2300; http://www.wjgnet.com/1007-9327/full/v18/i19/2300.htm. ISSN: 1007-9327.
  40. Protective effects of curcumin, α-lipoic acid, and N-acetylcysteine against carbon tetrachloride-induced liver fibrosis in rats. Morsy, Mohamed A., et al., et al. [ed.] A. Barber and M. Pilar Lostao. 1, s.l.: Springer, March 1, 2012, Journal of Physiology and Biochemistry, Vol. 68, pp. 29-35. DOI: 10.1007/s13105-011-0116-0; http://link.springer.com/article/10.1007%2Fs13105-011-0116-0. ISSN: 1138-7548.
  41. National Toxicology Program. Report on Carcinogens - 12th Edition. s.l.: U.S. Department of Health and Human Services, 2011.
  42. Influence of thioctic acid (alpha-lipoic acid) on N-nitroso-diethylamine-induced carcinogenesis in male sprague-dawley rats. Habs, M., Habs, H., Schmähl, D. [ed.] Martin Wehling. 10, Mannheim: Georg Thieme Verlag KG, 1980, Arzneimittel-Forschung, Vol. 30, pp. 1715-1717. ISSN: 0004-4172.
  43. Prasad, Kedar N. Micronutrients for Improvement of the Standard Therapy in Cancer. Micronutrients in Health and Disease. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2011, 8, pp. 133-166. ISBN: 978-1-4398-2106-0.
  44. Mumber, Matt P. Colorectal Cancer. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 78, pp. 718-725.e2. ISBN: 978-1-4377-1793-8.
  45. Prasad, Kedar N. Micronutrients for the Prevention of Diabetes and Improvement of the Standard Therapy. Micronutrients in Health and Disease. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2011, 6, pp. 77-102. ISBN: 978-1-4398-2106-0.
  46. Diabetes and Alpha Lipoic Acid. Golbidi, Saeid, Badran, Mohammad and Laher, Ismail. [ed.] Adolfo Andrade-Cetto. 69, Lausanne: Frontiers Media S.A., November 17, 2011, Frontiers in Ethnopharmacology, Vol. 2. DOI: 10.3389/fphar.2011.00069; http://journal.frontiersin.org/article/10.3389/fphar.2011.00069/abstract. ISSN: 1663-9812.
  47. Study of Comparative Effects of Antioxidants on Insulin Sensitivity in Type 2 Diabetes Mellitus. Udupa, A.S., et al., et al. 9, Delhi: Dr. Hemant Jain: JCDR Research and Publications (P) Limited, November 2012, Journal of Clinical and Diagnostic Research, Vol. 6, pp. 1469-1473. ISSN: 2249-782X.
  48. a-Lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice. Lee, Young, et al., et al. [ed.] William J. Lennarz. 1, Stony Brook: Elsevier Inc., May 26, 2006, Biochemical and Biophysical Research Communications, Vol. 344, pp. 446-452. DOI: 10.1016/j.bbrc.2006.03.062; http://www.sciencedirect.com/science/article/pii/S0006291X06005377. ISSN: 0006-291X.
  49. Effect of Combined Treatment with Alpha Lipoic Acid and Acetyl-L-Carnitine on Vascular Function and Blood Pressure in Coronary Artery Disease Patients. McMackin, Craig J., et al., et al. [ed.] Marvin Moser. 4, Greenwich: Wiley Periodicals, Inc., April 2007, The Journal of Clinical Hypertension, Vol. 9, pp. 249-255. DOI: 10.1111/j.1524-6175.2007.06052.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1524-6175.2007.06052.x/abstract. eISSN: 1751-7176.
  50. Effects of Alpha-Lipoic Acid on Body Weight in Obese Subjects. Koh, Eun Hee, et al., et al. [ed.] Joseph S. Alpert. 1, Tucson: Elsevier Inc., January 2011, The American Journal of Medicine, Vol. 124, pp. 85.e1-8. DOI: 10.1016/j.amjmed.2010.08.005; http://www.amjmed.com/article/S0002-9343(10)00743-6/abstract. ISSN: 0002-9343.
  51. Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study. Sola, Srikanth, et al., et al. [ed.] Joseph Loscalzo. 3, Boston: American Heart Association, Inc., January 25, 2005, Circulation, Vol. 111, pp. 343-348. DOI: 10.1161/01.CIR.0000153272.48711.B9; http://circ.ahajournals.org/content/111/3/343. ISSN: 0009-7322.
  52. Diabetic Bladder Dysfunction: Current Translational Knowledge. Daneshgari, Firouz, et al., et al. [ed.] Bradley P. Kropp. 6 Suppl, Linthicum: American Urological Association, December 2009, The Journal of Urology®, Vol. 182, pp. S18-S26. DOI: 10.1016/j.juro.2009.08.070; http://www.jurology.com/article/S0022-5347(09)02092-8/abstract. ISSN: 0022-5347.
  53. Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study. Porasuphatana, Supatra, et al., et al. [ed.] Meei-Shyuan Lee. 1, Cambridge: John Wiley and Sons, Inc., 2012, Asia Pacific Journal of Clinical Nutrition, Vol. 21, pp. 12-21. ISSN: 0964-7058.
  54. Effects of Controlled-Release Alpha Lipoic Acid In Lean, Nondiabetic Patients with Polycystic Ovary Syndrome. Masharani, Umesh, et al., et al. [ed.] David C. Klonoff. 2, Burlingame: Sage Journals: Diabetes Technology Society, March 2010, Journal of Diabetes Science and Technology, Vol. 4, pp. 359-364. DOI: 10.1177/193229681000400218; http://dst.sagepub.com/content/4/2/359. ISSN: 1932-2968.
  55. Gruner, Tini. The Endocrine System. [ed.] Leah Hechtman. Clinical Naturopathic Medicine. Revised. Chatswood: Elsevier Australia, 2012, 17, pp. 1025-1137. ISBN: 978-0-7295-3885-5.
  56. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Midaoui, Adil E.L., et al., et al. [ed.] John H. Laragh. 3, New York: Oxford University Press, March 3, 2003, American Journal of Hypertension, Vol. 16, pp. 173-179. DOI: 10.1016/S0895-7061(02)03253-3; http://ajh.oxfordjournals.org/content/16/3/173. ISSN: 0895-7061.
  57. Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes. Du, X., Edelstein, D. and Brownlee, M. [ed.] Edwin Gale. 10, s.l.: Springer-Verlag: European Association for the Study of Diabetes, October 2008, Diabetologia, Vol. 51, pp. 1930-1932. Trial registration: NCT00703989; DOI: 10.1007/s00125-008-1100-2; http://link.springer.com/article/10.1007%2Fs00125-008-1100-2. ISSN: 0012-186X.
  58. Role of advanced glycation end products in cardiovascular disease. Hegab, Zeinab, et al., et al. [ed.] Raúl Moreno and Victor L. Serebruany. 4, Hong Kong: Baishideng Publishing Group Co., Limited, April 26, 2012, World Journal of Cardiology, Vol. 4, pp. 90-102. DOI: 10.4330/wjc.v4.i4.90; http://www.wjgnet.com/1949-8462/full/v4/i4/90.htm. ISSN: 1949-8462.
  59. Making insulin-deficient type 1 diabetic rodents thrice without insulin. Yu, Xinxin, et al., et al. [ed.] Randy Schekman. 37, Berkeley: The National Academy of Sciences of the USA, September 16, 2008, Proceedings of the National Academy of Sciences, Vol. 105, pp. 14070-14075. DOI: 10.1073/pnas.0806993105; http://www.pnas.org/content/105/37/14070. ISSN: 1091-6490.
  60. Nahas, Richard. Type 2 Diabetes. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 32, pp. 297-311.e3. ISBN: 978-1-4377-1793-8.
  61. Linkner, Edward (Lev) and Humphreys, Corene. Insulin Resistance and the Metabolic Syndrome. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 31, pp. 284-296.e4. ISBN: 978-1-4377-1793-8.
  62. α-Lipoic acid increases energy expenditure by enhancing adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor-γ coactivator-1α signaling in the skeletal muscle of aged mice. Wang, Yi, et al., et al. [ed.] Christos S. Mantzoros. 7, Boston: Elsevier Inc., July 2010, Metabolism Clinical and Experimental, Vol. 59, pp. 967-976. DOI: 10.1016/j.metabol.2009.10.018; http://www.metabolismjournal.com/article/S0026-0495(09)00449-1/abstract. ISSN: 0026-0495.
  63. A Combination of Lipoic Acid Plus Coenzyme Q10 Induces PGC1α, a Master Switch of Energy Metabolism, Improves Stress Response, and Increases Cellular Glutathione Levels in Cultured C2C12 Skeletal Muscle Cells. Wagner, A.E., et al., et al. [ed.] Michalis G. Nikolaidis. Article ID 835, Serres: Hindawi Publishing Corporation, February 22, 2012, Oxidative Medicine and Cellular Longevity, Vol. 2012, pp. 1-9. ; http://www.hindawi.com/journals/omcl/2012/835970/DOI: 10.1155/2012/835970. ISSN: 1942-0900.
  64. Lipoic acid prevents liver metabolic changes induced by administration of a fructose-rich diet. Castro, María C., et al., et al. [ed.] Elias Arnér and Sharon Krag. 1, Stockholm; London: Elsevier B.V., January 2013, Biochimica et Biophysica Acta (BBA) - General Subjects, Vol. 1830, pp. 2226-2232. DOI: 10.1016/j.bbagen.2012.10.010; http://www.sciencedirect.com/science/article/pii/S0304416512002905. ISSN: 0304-4165.
  65. α-Lipoic Acid is a Weak Dual PPARα/γ Agonist An Ester Derivative with Increased PPARα/γ Efficacy and Antioxidant Activity. Pershadsingh, Harrihar A., et al., et al. [ed.] Peter P. Toth. 4, Apopka: Therapeutic Solutions LLC, 2005, The Journal of Applied Research In Clinical and Experimental Therapeutics, Vol. 5, pp. 510-523. ISSN: 1537-064X.
  66. P048: Effects of combination therapy with fenofibrate and alpha-lipoic acid in patients with ischemic heart disease and type 2 diabetes mellitus. Zhuravlyova, L., Lopina, N. [ed.] Francisco Fernandez-Aviles. suppl A, Hong Kong: Oxford University Press: European Society of Cardiology, February 24-26, 2012, European Heart Journal Abstracts from the International Congress of Cardiology, Vol. 14, pp. A14-A19. DOI: 10.1093/eurheartj/sur025; http://eurheartjsupp.oxfordjournals.org/content/14/suppl_A/A14. ISSN: 1520-765X.
  67. Astapova, Olga and Leff, Todd. Adiponectin and PPARγ: Cooperative and Interdependent Actions of Two Key Regulators of Metabolism. [ed.] Gerald Litwack. Adiponectin. London: Elsevier Inc., 2012, 6, pp. 143-162. ISBN: 978-0-12-398313-8.
  68. National Institutes of Health. National Kidney and Urologic Diseases Information Clearinghouse: Erectile Dysfunction. The National Institute of Diabetes and Digestive and Kidney Diseases. [Online] November 2015. [Cited: November 25, 2015.] http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/erectile-dysfunction/Pages/facts.aspx. NIH Publication No. 09-3923.
  69. Effect of Transdermal Testosterone or Alpha-Lipoic Acid on Erectile Dysfunction and Quality of Life in Patients with Type 2 Diabetes Mellitus. Mitkov, Mitko D., Aleksandrova, Ivanka Y. and Orbetzova, Maria M. [ed.] Stefan Kostianev. 1, Plovdiv : Walter de Gruyter GmbH: Medical University-Plovdiv, August 17, 2013, Folia Medica, Vol. 55, pp. 55-63. DOI: 10.2478/folmed-2013-0006; http://www.degruyter.com/view/j/folmed.2013.55.issue-1/folmed-2013-0006/folmed-2013-0006.xml. ISSN: 0204-8043.
  70. Torkos, Sherry. The Canadian Encyclopedia of Natural Medicine. Mississauga: John Wiley and Sons Canada, Ltd., 2008. ISBN: 978-0-470-83908-9.
  71. Balch, James and Stengler, Mark. Prescription for Natural Cures: A Self-Care Guide for Treating Health Problems with Natural Remedies Including Diet and Nutrition, Nutritional Supplements, Bodywork, and More. Hoboken: John Wiley & Sons, Inc., 2004. ISBN: 0-471-49088-1.
  72. Harris, Gardiner. F.D.A. to Restrict Avandia, Citing Heart Risk. The New York Times. September 24, 2010, p. A1.
  73. O'Connor, Anahad. Diabetes Drugs Carry Vision Risks. The New York Times. June 11, 2012.
  74. Alzheimer's Scary Link To Diabetes. Rovner, Sophie L. [ed.] Rudy M. Baum. 20, Washington D.C.: American Chemical Society, May 18, 2009, Chemical & Engineering News, Vol. 87, pp. 42-46. ; http://pubs.acs.org/doi/abs/10.1021/cen-v087n020.p042DOI: 10.1021/cen-v087n020.p042. ISSN: 0009-2347.
  75. Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease. de la Monte, Suzanne M. [ed.] Debomoy K. Lahiri. 1, Indianapolis: Bentham Science Publishers, January 2012, Current Alzheimer Research, Vol. 9, pp. 35-66. DOI: 10.2174/156720512799015037; http://www.eurekaselect.com/88685/article. ISSN: 1567-2050.
  76. Tortora, Gerard J. and Derrickson, Bryan. The Cellular Level of Organization. Principles of Anatomy & Physiology. Hoboken: John Wiley & Sons, Inc., 2012, 3, pp. 63-112. ISBN-13: 978-0470-56510-0.
  77. Possible Roles of Proinflammatory and Chemoattractive Cytokines Produced by Human Fetal Membrane Cells in the Pathology of Adverse Pregnancy Outcomes Associated with Influenza Virus Infection. Uchide, Noboru, et al., et al. [ed.] Felipe Vadillo-Ortega. Article ID 270670, Mexico City: Hindawi Publishing Corporation, April 27, 2012, Mediators of Inflammation, Vol. 2012, pp. 1-32. DOI: 10.1155/2012/270670; http://www.hindawi.com/journals/mi/2012/270670/. ISSN: 0962-9351.
  78. Antioxidant capacity in mellitus diabetes. Mateescu, Rodica, et al., et al. [ed.] Nesrin Kartal Ozer. Istanbul: Society for Free Radical Research (SFRR) - Europe, 2011. p. 108. P3-075.
  79. α-Lipoic Acid Treatment Decreases Serum Lactate and Pyruvate Concentrations and Improves Glucose Effectiveness in Lean and Obese patients with Type 2 Diabetes. Konrad, Thomas, et al., et al. [ed.] Jr. Charles M. Clark. 2, Alexandria: American Diabetes Association, February 1999, Diabetes Care, Vol. 22, pp. 280-287. DOI: 10.2337/diacare.22.2.280; http://care.diabetesjournals.org/content/22/2/280. ISSN: 0149-5992.
  80. Hingorani, Aroon, Vallance, Patrick and MacAllister, Raymond. Clinical Pharmacology of Cardiovascular Drugs. [book auth.] European Society of Cardiology. [ed.] A. John Camm, Thomas F. Lüscher and Patrick W. Serruys. The ESC Textbook of Cardiovascular Medicine. Oxford: Blackwell Publishing Ltd., 2006, 8, pp. 219-242. ISBN-13: 978-1-4051-2695-3.
  81. Cosentino, Francesco, Ryden, Lars and Francia, Pietro. Diabetes Mellitus and Metabolic Syndrome. [ed.] A. John Camm, Thomas F. Lüscher and Patrick W. Serruys. The ESC Textbook of Cardiovascular Medicine. Oxford: Blackwell Publishing Ltd., 2006, 11, pp. 301-332. ISBN-13: 978-1-4051-2695-3.
  82. Lipid Lowering Effect of Antioxidant Alpha-Lipoic Acid in Experimental Atherosclerosis. Amom, Zulkhairi, et al., et al. [ed.] Toshikazu Yoshikawa. 2, Tokyo: Nakanishi Printing Co., Ltd.: The Society for Free Radical Research Japan, September 2008, Journal of Clinical Biochemistry and Nutrition, Vol. 43, pp. 88-94. DOI: 10.3164/jcbn.2008051; https://www.jstage.jst.go.jp/article/jcbn/43/2/43_2008051/_article. ISSN: 0912-0009.
  83. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?. Gianturco, V., et al., et al. [ed.] Imre Zs.-Nagy. Suppl 1, Debrecen: Elsevier Ireland Ltd., February 26-28, 2009, Archives of Gerontology and Geriatrics, Vol. 49, pp. 129-133. DOI: 10.1016/j.archger.2009.09.022; http://www.aggjournal.com/article/S0167-4943(09)00222-2/abstract. ISSN: 0167-4943.
  84. Experimental Study of the Neuroprotective Properties of Alpha-Lipoic Acid and Superoxide Dismutase in Cerebral Ischemia in Rats. Shmonin, A.A., et al., et al. [ed.] Charles D. Woody. 5, Los Angeles: Springer US, June 2012, Neuroscience and Behavioral Physiology, Vol. 42, pp. 429-433. DOI: 10.1007/s11055-012-9583-1; http://link.springer.com/article/10.1007%2Fs11055-012-9583-1. ISSN: 0097-0549.
  85. a-Lipoic Acid in the Treatment of Diabetic Peripheral and Cardiac Autonomic Neuropathy. Ziegler, Dan and Gries, F. Arnold. [ed.] Gordon C. Weir. Suppl 2, Boston: American Diabetes Association, September 1997, Diabetes, Vol. 46, pp. S62-S66. DOI: 10.2337/diab.46.2.S62; http://diabetes.diabetesjournals.org/content/46/Supplement_2/S62. ISSN: 0012-1797.
  86. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial. Heinisch, B.B. and Francesconi, M. [ed.] John P.A. Ioannidis. 2, Stanford: Stichting: European Society for Clinical Investigation Journal Foundation, February 2010, European Journal of Clinical Investigation, Vol. 40, pp. 148-154. DOI: 10.1111/j.1365-2362.2009.02236.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2362.2009.02236.x/abstract. ISSN: 1365-2362.
  87. Effect of α-Lipoic Acid on Platelet Reactivity in Type 1 Diabetic Patients. Mollo, Roberto, et al., et al. [ed.] William T. Cefalu. 2, Alexandria: American Diabetes Association, February 2012, Diabetes Care, Vol. 35, pp. 196-197. DOI: 10.2337/dc11-1255; http://care.diabetesjournals.org/content/35/2/196. ISSN: 0149-5992.
  88. Houston, Mark C. Hypertension: Nutrition, Nutraceuticals, Vitamins, Antioxidants, and Minerals in Prevention and Treatment. [ed.] Ingrid Kohlstadt. Advancing Medicine with Food and Nutrients. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2012, 6, pp. 105-134. ISBN: 978-1-4398-8772-1.
  89. Alpha-Lipoic Acid Ameliorates Oxidative Stress by Increasing Aldehyde Dehydrogenase-2 Activity in Patients with Acute Coronary Syndrome. Li, Rui-Jian, et al., et al. [ed.] Shigeki Shibahara. 1, Sendai: Tohoku University Medical Press, January 2013, The Tohoku Journal of Experimental Medicine, Vol. 29, pp. 45-51. DOI: 10.1620/TJEM.229.45; https://www.jstage.jst.go.jp/article/tjem/229/1/229_45/_article. ISSN: 0040-8727.
  90. Heart Disease: Symptoms, Diagnosis, Treatment. National Institutes of Health; Friends of the National Library of Medicine. [ed.] Donald West King, et al., et al. 1, Bethesda: Krames StayWell, Winter 2009, NIH MedlinePlus, Vol. 4, pp. 25-27. ISSN: 1937-4712.
  91. Lipoic acid effects on established atherosclerosis. Ying, Zhekang, et al., et al. [ed.] Bertil Fredholm and Frank Porreca. 3-4, Columbus: Elsevier Inc., January 16, 2010, Life Sciences, Vol. 86, pp. 95-102. ; http://www.sciencedirect.com/science/article/pii/S0024320509004640DOI: 10.1016/j.lfs.2009.11.009. ISSN: 0024-3205.
  92. Review article: Coagulation and fibrinolysis in diabetes. Alzahrani, S.H. and Ajjan, R.A. [ed.] Peter Grant. 4, Leeds: SAGE Publications, October 2010, Diabetes & Vascular Disease Research, Vol. 7, pp. 260-273. DOI: 10.1177/1479164110383723; http://dvr.sagepub.com/content/7/4/260. ISSN: 1479-1641.
  93. Houston, Mark C. Hypertension. [ed.] Ingrid Kohlstadt. Food and Nutrients in Disease Management. Boca Raton: CRC Press: Taylor & Francis Group, LLC, 2009, 5, pp. 75-108. ISBN-13: 978-1-4200-6762-0.
  94. Therapeutic perspectives on the combination of α-lipoic acid and vitamin E. Gonzalez-Perez, Oscar and Gonzalez-Castaneda, Rocio E. [ed.] Bruce A. Watkins. 1, New York: Elsevier Inc., January 1, 2006, Nutrition Research, Vol. 26, pp. 1-5. DOI: 10.1016/j.nutres.2005.11.011; http://www.nrjournal.com/article/S0271-5317(05)00281-2/abstract. ISSN: 0271-5317.
  95. Obesity, Inflammation, and the Potential Application of Pharmaconutrition. Cave, Matt C., et al., et al. [ed.] Jeanette Hasse. 1, Dallas: SAGE Publications: American Society for Parenteral and Enteral Nutrition, February 2008, Nutrition in Clinical Practice, Vol. 23, pp. 16-34. DOI: 10.1177/011542650802300116; http://ncp.sagepub.com/content/23/1/16. ISSN: 0884-5336.
  96. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. He, Lan, et al., et al. [ed.] F.P. Nijkamp. 1-3, Utrecht: Elsevier B.V., March 5, 2012, European Journal of Pharmacology, Vol. 678, pp. 32-38. DOI: 10.1016/j.ejphar.2011.12.042; http://www.sciencedirect.com/science/article/pii/S0014299912000040. ISSN: 0014-2999.
  97. Co-Administration of Resveratrol and Lipoic Acid, or Their Synthetic Combination, Enhances Neuroprotection in a Rat Model of Ischemia/Reperfusion. Saleh, Monique C., et al., et al. [ed.] Vardan Karamyan. 1, Amarillo: Public Library of Science, January 31, 2014, PLoS ONE, Vol. 9, p. e87865. DOI: 10.1371/journal.pone.0087865; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0087865. ISSN: 1932-6203.
  98. The Impact of Lipoic Acid on Endothelial Function and Proteinuria in Quinapril-Treated Diabetic Patients With Stage I Hypertension: Results From the QUALITY Study. Rahman, Syed T., et al., et al. [ed.] Robert A. Kloner. 2, Los Angeles: SAGE Publications, June 2012, Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 17, pp. 139-145. DOI: 10.1177/1074248411413282; http://cpt.sagepub.com/content/17/2/139. ISSN: 1074-2484.
  99. α-Lipoic Acid Prevents Endothelial Dysfunction in Obese Rats via Activation of AMP-Activated Protein Kinase. Lee, Woo Je, et al., et al. [ed.] Donald D. Heistad. 12, Iowa City: American Heart Association, Inc., December 2005, Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, pp. 2488-2494. DOI: 10.1161/01.ATV.0000190667.33224.4c; http://atvb.ahajournals.org/content/25/12/2488. ISSN: 1079-5642.
  100. Effect of Vitamin E and Alpha Lipoic Acid in Nonalcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled, Open-Label, Prospective Clinical Trial (VAIN Trial). Basu, Patrick P., et al., et al. [ed.] Weizhen Zhang. 5, Beijing: Scientific Research Publishing Inc., May 2, 2014, Open Journal of Gastroenterology, Vol. 4, pp. 1-9. DOI: 10.4236/ojgas.2014.45030; http://www.scirp.org/journal/PaperDownload.aspx?DOI=10.4236/ojgas.2014.45030. ISSN: 2163-9450.
  101. Effects of Nutraceuticals and Botanicals on Macrophage Cholesterol Efflux: Implications for Atherosclerosis. Sotherden, Grace Megumi, et al., et al. [ed.] Ghazala Hafeez Rizwani. 2, Karachi: Lifescience Global, December 31, 2012, Journal of Nutritional Therapeutics, Vol. 1, pp. 96-106. DOI: 10.6000/1929-5634.2012.01.02.1; http://www.lifescienceglobal.com/journals/journal-of-nutritional-therapeutics/volume-1-number-2. eISSN: 1929-5634.
  102. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Mehta, Puja K. and Griendling, Kathy K. [ed.] Dennis Brown. 1, Boston: American Physiological Society, January 1, 2007, American Journal of Physiology - Cell Physiology®, Vol. 292, pp. C82-C97. DOI: 10.1152/ajpcell.00287.2006; http://ajpcell.physiology.org/content/292/1/C82. ISSN: 0363-6143.
  103. López-Farré, Antonio J., et al., et al. Protective Effect of Vitamin C on Vascular Damage and Arterial Hypertension Induced by Low-Level Mercury and Lead Exposure. [ed.] Hubert Kucharski and Julek Zajac. Handbook of Vitamin C Research. New York: Nova Science Publishers, Inc., 2009, 13, pp. 329-342. ISBN: 978-1-60741-874-0.
  104. Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. Packer, Lester and Cadenas, Enrique. [ed.] Toshikazu Yoshikawa. 1, Kyoto: Society for Free Radical Research Japan, January 2011, Journal of Clinical Biochemistry and Nutrition, Vol. 48, pp. 26-32. DOI: 10.3164/jcbn.11-005FR; https://www.jstage.jst.go.jp/article/jcbn/48/1/48_11-005FR/_article. ISSN: 0912-0009.
  105. Lockwood, Brian. Synergism, beneficial interactions and combination products. Nutraceuticals: A guide for healthcare professionals. 2nd. Cornwall: Pharmaceutical Press: RPS Publishing, 2007, 20, pp. 339-358. ISBN: 978-0-85369-659-9.
  106. Warber, Sara L. and Zick, Suzanna M. Coronary Artery Disease. [ed.] David Rakel. Integrative Medicine. Philadelphia: Saunders: Elsevier Science, 2003, 21, pp. 173-186. ISBN: 0-7216-9288-5.
  107. Lipoic acid protects against reperfusion injury in the early stages of cerebral ischemia. Connell, Barry J., et al., et al. [ed.] Irwin B. Levitan. Philadelphia: Elsevier B.V., February 23, 2011, Brain Research, Vol. 1375, pp. 128-136. DOI: 10.1016/j.brainres.2010.12.045; http://www.sciencedirect.com/science/article/pii/S0006899310027101. ISSN: 0006-8993.
  108. Effects of Alpha-Lipoic Acid Supplementation on Inflammation, Oxidative Stress, and Serum Lipid Profile Levels in Patients With End-Stage Renal Disease on Hemodialysis. Khabbazi, Tannaz, et al., et al. [ed.] Jerrilynn D. Burrowes and Christoph Wanner. 2, Brookville; Wüerzburg: Elsevier Inc.: National Kidney Foundation, Inc., March 2012, Journal of Renal Nutrition, Vol. 22, pp. 244-250. DOI: 10.1053/j.jrn.2011.06.005; http://www.jrnjournal.org/article/S1051-2276(11)00117-8/abstract. ISSN: 1051-2276.
  109. Alpha-lipoic Acid Improves Endothelial Dysfunction in Patients with Subclinical Hypothyroidism. Giang, G.D., et al., et al. [ed.] Thomas Gudermann and Peter Nawroth. 9, Munich; Heidelberg: Georg Thieme Verlag KG, October 2010, Experimental and Clinical Endocrinology & Diabetes, Vol. 118, pp. 625-629. DOI: 10.1055/s-0029-1237702; https://www.thieme-connect.de/DOI/DOI?10.1055/s-0029-1237702. ISSN: 0947-7349.
  110. The Effect of Alpha Lipoic Acid (Thioctacid HR®) on Endothelial Function in Diabetic and Hypertensive Patients. Lee, Sang Rok, et al., et al. [ed.] Se Joong Rim. 8, Seoul: The Korean Society of Circulation, August 2006, Korean Circulation Journal, Vol. 36, pp. 559-564. DOI: 10.4070/kcj.2006.36.8.559; http://synapse.koreamed.org/DOIx.php?id=10.4070/kcj.2006.36.8.559. ISSN: 1738-5520.
  111. Mindell, Earl and Colman, Carol. The Hot Hundred. Earl Mindell's Peak Performance Bible: How to Look Great, Feel Great, and Perform Better In the Gym, At Work, and In Bed. New York: Simon and Schuster, Inc., 2001, 2, pp. 19-172. ISBN: 0-7432-0437-9.
  112. Effects of R-Alpha Lipoic Acid on HbA1c, Lipids and Blood Pressure in Type-2 Diabetics: A Preliminary Study. Lukaszuk, Judith M., et al., et al. [ed.] Edmund M.K. Lui. 1, London, Ontario: Berkeley Electronic Press, October 6, 2009, Journal of Complementary and Integrative Medicine, Vol. 6. DOI: 10.2202/1553-3840.1297; http://www.degruyter.com/view/j/jcim.2009.6.1/jcim.2009.6.1.1297/jcim.2009.6.1.1297.xml. ISSN: 1553-3840.
  113. Cardiovascular Autonomic Dysfunctions in Diabetic Patients: Therapeutic Effect of Alpha Lipoic Acid. Milanov, S., et al., et al. Barcelona: Sherborne Gibbs, 2007. Abstracts of the 2nd International Congress on "Prediabetes" and the Metabolic Syndrome. Vols. 4, Supplement 1, p. S157. PMID: 175336.
  114. Why America Is Fatter and Sicker Than Ever. Agatston, Arthur. [ed.] Joseph Loscalzo. 1, Boston: American Heart Association, Inc., July 3, 2012, Circulation, Vol. 126, pp. e3-e5. DOI: 10.1161/CIRCULATIONAHA.112.098566; http://circ.ahajournals.org/content/126/1/e3. ISSN: 0009-7322.
  115. The Effect of Alpha-Lipoic Acid on Blood Pressure in Type 2 Diabetics. Mazloom, Z. and Ansar, H. [ed.] Saleh Zahedi-Asl. 3, Tehran: Shaheed Beheshti University of Medical Sciences, 2009, Iranian Journal of Endocrinology and Metabolism, Vol. 11, pp. 245-250. ISSN: 1683-4844.
  116. α-Lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose. Xiang, Guangda, et al., et al. [ed.] Christos S. Mantzoros. 4, Boston: Elsevier B.V., April 2011, Metabolism Clinical and Experimental, Vol. 60, pp. 480-485. DOI: 10.1016/j.metabol.2010.04.011; http://www.metabolismjournal.com/article/S0026-0495(10)00130-7/abstract. ISSN: 0026-0495.
  117. Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome. Wray, D. Walter, et al., et al. [ed.] R. Clinton Webb. 5, Augusta: Portland Press Ltd: Biochemical Society, March 2009, Clinical Science, Vol. 116, pp. 433-441. DOI: 10.1042/CS20080337; http://www.clinsci.org/content/116/5/433. ISSN: 0143-5221.
  118. Antioxidant supplements in exercise: worse than useless?. Gomez-Cabrera, Mari Carmen, Ristow, Michael and Viña, Jose. [ed.] Charles H. Lang. 4, Bethesda: American Physiological Society, February 15, 2012, AJP - Endocrinology and Metabolism, Vol. 302, pp. E476-E477. DOI: 10.1152/ajpendo.00567.2011; http://ajpendo.physiology.org/content/302/4/E476. ISSN: 0193-184.
  119. Normal adaptations to exercise despite protection against oxidative stress. Higashida, Kazuhiko, et al., et al. [ed.] Charles H. Lang. 5, Bethesda: American Physiological Society, November 1, 2011, AJP-Endocrinology & Metabolism, Vol. 301, pp. E779-E784. DOI: 10.1152/ajpendo.00655.2010; http://ajpendo.physiology.org/content/301/5/E779. ISSN: 0193-184.
  120. Antioxidant Supplementation Reduces Skeletal Muscle Mitochondrial Biogenesis. Strobel, Natalie A., et al., et al. [ed.] Andrew J. Young. 6, Natick: American College of Sports Medicine, June 2011, Medicine & Science in Sports & Exercise, Vol. 43, pp. 1017-1024. DOI: 10.1249/MSS.0b013e318203afa3; http://journals.lww.com/acsm-msse/pages/articleviewer.aspx?year=2011&issue=06000&article=00013&type=abstract. ISSN: 0195-9131.
  121. Physical activity and alpha-lipoic acid modulate inflammatory response through changes in thiol redox status. Zembron-Lacny, A., et al., et al. [ed.] M. Pilar Lostao and Ana Barber. 3, Pamplona: Springer Netherlands, September 2013, Journal of Physiology and Biochemistry, Vol. 69, pp. 397-404. DOI: 10.1007/s13105-012-0221-8; http://link.springer.com/article/10.1007%2Fs13105-012-0221-8. ISSN: 1138-7548.
  122. Amelioration of Lipid Abnormalities by α-Lipoic acid Through Antioxidative and Anti-Inflammatory Effects. Zhang, Yongyan, et al., et al. [ed.] Richard Bergman and Marilyn Ader. 8, Los Angeles: John Wiley & Sons, Inc.: North American Association for the Study of Obesity, August 2011, Obesity, Vol. 19, pp. 1529-1726. DOI: 10.1038/oby.2011.121; http://onlinelibrary.wiley.com/doi/10.1038/oby.2011.121/abstract. ISSN: 1930-7381.
  123. Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. McNeilly, Andrea M, et al., et al. [ed.] Undurti N. Das. 217, London: BioMed Central Ltd., November 22, 2011, Lipids in Health and Disease, Vol. 10. DOI: 10.1186/1476-511X-10-217; http://www.lipidworld.com/content/10/1/217. ISSN: 1476-511X.
  124. Meydani, Mohsen, Kong, EunHee and Knight, Ashley. LDL Oxidation as a Biomarker of Antioxidant Status. [ed.] Kyung-Jin Yeum, Etsuo Niki, Robert M. Russell Giancarlo Aldini. Biomarkers for Antioxidant Defense and Oxidative Damage. Ames: Blackwell Publishing: John Wiley & Sons, 2010, 4, pp. 51-64. ISBN-13: 978-0-8138-1535-0.
  125. Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial. Woodside, Jayne V., et al., et al. [ed.] Steve E. Humphries. 2, London: Elsevier Inc., June 1999, Atherosclerosis, Vol. 144, pp. 419-427. DOI: 10.1016/S0021-9150(98)00334-7; http://www.atherosclerosis-journal.com/article/S0021-9150(98)00334-7/abstract. ISSN: 0021-9150.
  126. Ahima, Rexford S. Principles of Obesity Therapy. Metabolic Basis of Obesity. New York: Springer Science+Business Media, LLC, 2011, 19, pp. 359-380. ISBN: 978-1-4419-1606-8; DOI: 10.1007/978-1-4419-1607-5.
  127. Ahima, Rexford S. and Goncalves, Marcus D. Adipokines in Health and Disease. [ed.] Rexford S. Ahima. Metabolic Basis of Obesity. New York: Springer Science+Business Media, LLC, 2011, 4, pp. 69-88. ISBN: 978-1-4419-1606-8; DOI: 10.1007/978-1-4419-1607-5.
  128. Kawada, Teruo, et al., et al. Obesity and Nuclear Receptors: Effective Genomic Strategies in Functional Foods. [ed.] Yoshinori Mine, Kazuo Miyashita and Fereidoon Shahidi. Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions. Ames: Wiley-Blackwell, 2009, 4, pp. 47-58. ISBN: 978-0-813-80033-2.
  129. Foss-Morgan, Roberta. 9 Simple Weight Loss Tips. What Your Doctor Won't Tell You About Weight Loss: Mesotherapy And More. Lincoln: iUniverse, 2004, 3, pp. 11-17. ISBN: 0-595-32229-8.
  130. Salmond, Ses. The Hepatobiliary System. [ed.] Leah Hechtman. Clinical Naturopathic Medicine. Revised, 1e. Chatswood: Elsevier Australia, 2012, 8, pp. 210-279. ISBN-13: 978-0729541510.
  131. α-Lipoic Acid Supplementation: A Tool for Obesity Therapy? Carbonelli, M.G., et al., et al. [ed.] William A. Banks. 7, Seattle: Bentham Science Publishers, March 2010, Current Pharmaceutical Design, Vol. 16, pp. 840-846. DOI: 10.2174/138161210790883589; http://www.eurekaselect.com/71104/article. ISSN: 1381-6128.
  132. A Preliminary Investigation of [alpha]-Lipoic Acid Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia. Kim, Eosu, et al., et al. [ed.] Richard I. Shader and David J. Greenblatt. 2, Medford: Lippincott Williams & Wilkins, Inc., April 2008, Journal of Clinical Psychopharmacology, Vol. 28, pp. 138-146. DOI: 10.1097/JCP.0b013e31816777f7; http://journals.lww.com/psychopharmacology/pages/articleviewer.aspx?year=2008&issue=04000&article=00003&type=abstract. ISSN: 0271-0749.
  133. Diet-induced Obesity Alters AMP Kinase Activity in Hypothalamus and Skeletal Muscle. Martin, Tonya L., et al., et al. [ed.] Herbert Tabor. 28, New York: American Society for Biochemistry and Molecular Biology, July 14, 2006, The Journal of Biological Chemistry, Vol. 281, pp. 18933-18941. DOI: 10.1074/jbc.M512831200; http://www.jbc.org/content/281/28/18933. ISSN: 0021-9258.
  134. Tornheim, Keith and Ruderman, Neil B. Intermediary Metabolism of Carbohydrate, Protein, and Fat. [ed.] Rexford S. Ahima. Metabolic Basis of Obesity. New York: Springer Science+Business Media, LLC, 2011, 2, pp. 25-52. ISBN: 978-1-4419-1606-8; DOI: 10.1007/978-1-4419-1607-5.
  135. Studies on Mechanistic Role of Natural Bioactive Compounds in the Management of Obesity An Overview. Alves, Natalia E.G., et al., et al. [ed.] Ram B. Singh. Moradabad: Bentham Open, December 28, 2012, The Open Nutraceuticals Journal, Vol. 5, pp. 193-206. DOI: 10.2174/1876396001205010193; http://benthamopen.com/ABSTRACT/TONUTRAJ-5-193. ISSN: 1876-3960.
  136. Response to letter to the editor by Gomez-Cabrera et al. Holloszy, J.O., et al., et al. [ed.] Charles H. Lang. 4, Bethesda: American Physiological Society, February 15, 2012, AJP - Endocrinology and Metabolism, Vol. 302, pp. E478-E479. DOI: 10.1152/ajpendo.00596.2011; http://ajpendo.physiology.org/content/302/4/E478. ISSN: 0193-184.
  137. Effect of alpha-lipoic acid and time-of-day on interleukin-6 response to exhaustive exercise in humans. Lappalainen, Zekine. [ed.] Himanshu Gupta, et al., et al. 1, Nairobi: Academic Journals, January 2011, African Journal of Pharmacy and Pharmacology, Vol. 5, pp. 42-47. DOI: 10.5897/AJPP10.390; http://academicjournals.org/journal/AJPP/article-abstract/52B9D9E30666. ISSN: 1996-0816.
  138. Assessment of the Antioxidant Effectiveness of a-Lipoic Acid in Healthy Men Exposed to Muscle-Damaging Exercise. Zembron-Lacny, A., et al., et al. [ed.] Tomasz Brzozowski. 2, Kraków: Polish Physiological Society, June 2009, Journal of Physiology and Pharmacology, Vol. 60, pp. 139-143. ISSN: 0867-5910.
  139. Regulating the regulators: the role of transcriptional regulatory proteins in the adaptive response to exercise in human skeletal muscle. Little, Jonathan P. and Cochran, Andrew J.R. [ed.] David J. Paterson. 7, Oxford: The Physiological Society, April 1, 2011, The Journal of Physiology, Vol. 589, pp. 1511-1512. DOI: 10.1113/jphysiol.2011.205401; http://onlinelibrary.wiley.com/doi/10.1113/jphysiol.2011.205401/abstract. ISSN: 0022-3751.
  140. Lipoic acid supplementation prevents angiotensin II-induced renal injury. Mervaala, Eero, et al., et al. [ed.] Saulo Klahr. 2, St. Louis: Nature Publishing Group: International Society of Nephrology, August 2003, Kidney International, Vol. 64, pp. 501-508. DOI: 10.1046/j.1523-1755.2003.00108.x; http://www.nature.com/ki/journal/v64/n2/full/4493909a.html. ISSN: 0085-2538.
  141. α-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway. Kim, Hyunsoo, et al., et al. [ed.] L.M. Popescu. 2, Bucharest: Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd, February 2012, Journal of Cellular and Molecular Medicine, Vol. 16, pp. 273-286. DOI: 10.1111/j.1582-4934.2011.01294.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2011.01294.x/abstract. eISSN: 1582-4934.
  142. The Effect of Lipoic Acid on Cyanate Toxicity in Different Structures of the Rat Brain. Sokołowska, Maria, et al., et al. [ed.] Richard M. Kostrzewa. 3, Johnson City: Springer US, October 2013, Neurotoxicity Research, Vol. 24, pp. 345-357. DOI: 10.1007/s12640-013-9395-2; http://link.springer.com/article/10.1007%2Fs12640-013-9395-2. ISSN: 1029-8428.
  143. Effect of α-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Morcos, M., et al., et al. [ed.] Nigishi Hotta. 3, Tokyo: Elsevier Science Ireland Ltd., June 2001, Diabetes Research and Clinical Practice, Vol. 52, pp. 175-183. DOI: 10.1016/S0168-8227(01)00223-6; http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(01)00223-6/abstract. ISSN: 0168-8227.
  144. Clinical importance of thrombomodulin serum levels. Califano, F., et al., et al. [ed.] A.V. Greco and A. Gasbarrini. 3, Rome: Verduci Editore, May-June 2000, European Review for Medical and Pharmacological Sciences, Vol. 4, pp. 59-66. ISSN: 1128-3602.
  145. Nuclear erythroid 2-related factor 2: A novel potential therapeutic target for liver fibrosis. Yang, Jing-Jing, et al., et al. [ed.] A. Wallace Hayes. Andover: Elsevier Inc., September 2013, Food and Chemical Toxicology, Vol. 59, pp. 421-427. DOI: 10.1016/j.fct.2013.06.018; http://www.sciencedirect.com/science/article/pii/S0278691513003864. ISSN: 0278-6915.
  146. The effects of alpha lipoic acid on liver cells damages and apoptosis induced by polyunsaturated fatty acids. Kaya-Dagistanlia, Fatma, et al., et al. [ed.] A. Wallace Hayes. Andover: Elsevier B.V, March 2013, Food and Chemical Toxicology, Vol. 53, pp. 84-93. DOI: 10.1016/j.fct.2012.11.026; http://www.sciencedirect.com/science/article/pii/S0278691512008332. ISSN: 0278-6915.
  147. Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1/LKB1/AMPK pathway. Yang, Yi, et al., et al. [ed.] Bernhard Hennig. 11, Lexington: Elsevier Inc., July 15, 2014, The Journal of Nutritional Biochemistry, Vol. 25, pp. 1207-1217. DOI: 10.1016/j.jnutbio.2014.06.001; http://www.jnutbio.com/article/S0955-2863(14)00133-8/abstract. ISSN: 0955-2863.
  148. AMP-activated Protein Kinase: An Emerging Drug Target to Regulate Imbalances in Lipid and Carbohydrate Metabolism to Treat Cardio-Metabolic Diseases. Srivastava, Rai Ajit K., et al., et al. [ed.] Edward A. Dennis and Joseph L. Witztum. 12, San Diego: American Society for Biochemistry and Molecular Biology, July 13, 2012, The Journal of Lipid Research, Vol. 53, pp. 2490-2514. DOI: 10.1194/jlr.R025882; http://www.jlr.org/content/53/12/2490. ISSN: 0022-2275.
  149. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Park, Keun-Gyu, et al., et al. [ed.] Keith D. Lindor. 5, Rochester: John Wiley & Sons, Inc.: American Association for the Study of Liver Diseases, November 2008, Vol. 48, pp. 1477-1486. DOI: 10.1002/hep.22496; http://onlinelibrary.wiley.com/doi/10.1002/hep.22496/abstract. eISSN: 1527-3350.
  150. α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β. Foo, Ning-Ping, et al., et al. [ed.] H.W.J. Marquardt and K.B. Wallace. 1-2, Shannon: Elsevier Ireland Ltd., March 28, 2011, Toxicology, Vol. 282, pp. 39-46. DOI: 10.1016/j.tox.2011.01.009; http://www.sciencedirect.com/science/article/pii/S0300483X11000138. ISSN: 0300-483X.
  151. St. John, Tina M. Chronic Hepatitis. [ed.] David Rakel. Integrative Medicine. 3rd. Philadelphia: Saunders: Elsevier Inc., 2012, 19, pp. 171-186.e4. ISBN: 978-1-4377-1793-8.
  152. Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety. Gianturco, Vincenzo, et al., et al. [ed.] Masao Omata and Shiv Kumar Sarin. 2, Kōfu; New Delhi: Springer India, June 1, 2013, Hepatology International, Vol. 7, pp. 570-576. DOI: 10.1007/s12072-012-9387-y; http://link.springer.com/article/10.1007%2Fs12072-012-9387-y. ISSN: 1936-0533.
  153. Acetyl-l-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Kathirvel, Elango, et al., et al. [ed.] Bruce A. Watkins. 11, New York: Elsevier Inc., November 2013, Nutrition Research, Vol. 33, pp. 932-941. DOI: 10.1016/j.nutres.2013.08.001; http://www.nrjournal.com/article/S0271-5317(13)00187-5/abstract. ISSN: 0271-5317.
  154. Flaxseed oil and alpha-lipoic acid combination ameliorates hepatic oxidative stress and lipid accumulation in comparison to lard. Xu, Jiqu. [ed.] Undurti N. Das. 58, London: BioMed Central Ltd., May 1, 2013, Lipids in Health and Disease, Vol. 12, pp. 1-7. DOI: 10.1186/1476-511X-12-58; http://www.lipidworld.com/content/12/1/58. ISSN: 1476-511X.
  155. Dietary Choline Deficiency causes DNA Strand Breaks and Alters Epigenetic Marks on DNA and Histones. Zeisel, Steven H. [ed.] P.J. Stambrook. 1-2, Cincinnati: Elsevier B.V., May 2012, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 733, pp. 34-38. DOI: 10.1016/j.mrfmmm.2011.10.008; http://www.sciencedirect.com/science/article/pii/S0027510711002739. ISSN: 0027-5107.
  156. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats. Fujii, Yuta, et al., et al. [ed.] Daniel Dietrich. 2, Konstanz: Elsevier Ireland Ltd., September 25, 2013, Chemico-Biological Interactions, Vol. 205, pp. 108-118. DOI: 10.1016/j.cbi.2013.06.017; http://www.sciencedirect.com/science/article/pii/S0009279713001579. ISSN: 0009-2797.
  157. Mandelker, Lester. Oxidative Stress, Free Radicals, and Cellular Damage. [ed.] Lester Mandelker and Peter Vajdovich. Studies on Veterinary Medicine. New York: Humana Press: Springer Science+Business Media, LLC, 2011, Vol. Oxidative Stress in Applied Basic Research and Clinical Practice, pp. 1-18. ISBN: 978-1-61779-070-6.
  158. Messonnier, Shawn. Nutritional Supplements for the Veterinary Practice. Lakewood: American Animal Hospital Association Press, 2012. ISBN: 978-1-58326-174-3.
  159. Garland, Tam. Inorganic Arsenicals (Toxicity). The Merck Veterinary Manual. [Online] April 2015. [Cited: November 28, 2015.] ; http://www.merckvetmanual.com/mvm/toxicology/arsenic_poisoning/inorganic_arsenicals_toxicity.html.
  160. Head, Elizabeth and Zicker, Steven C. Oxidative Stress, Cognitive Dysfunction, and Brain Aging. [ed.] Lester Mandelker and Peter Vajdovich. Studies on Veterinary Medicine. New York: Humana Press: Springer Science+Business Media, LLC, 2011, Vol. Oxidative Stress in Applied Basic Research and Clinical Practice, pp. 101-112. ISBN: 978-1-61779-070-6.
  161. Kuck, John. Nutrient Selection in the Management of Canine Atopic Dermatitis. [ed.] Lester Mandelker and Peter Vajdovich. Studies on Veterinary Medicine. New York: Humana Press: Springer Science+Business Media, LLC, 2011, Vol. Oxidative Stress in Applied Basic Research and Clinical Practice. ISBN: 978-1-61779-070-6.
  162. An Introduction to the Clinical Use of Nutraceutical and Botanical Therapies in Small Animal Practice. Silver, Robert J. Denver: s.n., 2011. Colorado Veterinary Medical Association Annual Conference. pp. 15-16. Lecture 3.
  163. Therapy and outcome of suspected alpha lipoic acid toxicity in two dogs. Loftin, Erika G. and Herold, Lee V. [ed.] Shane Bateman. 5, Columbus: John Wiley & Sons, Inc., October 2009, Journal of Veterinary Emergency and Critical Care, Vol. 19, pp. 501-506. DOI: 10.1111/j.1476-4431.2009.00460.x; http://onlinelibrary.wiley.com/doi/10.1111/j.1476-4431.2009.00460.x/abstract. eISSN: 1476-4431.
Disclaimer: This website is not intended to replace professional consultation, diagnosis, or treatment by a licensed physician. If you require any medical related advice, contact your physician promptly. Information presented on this website is exclusively of a general reference nature. Do not disregard medical advice or delay treatment as a result of accessing information at this site.